Intravitreal bevacizumab [IVB] for macular edema secondary to branch retinal vein occlusion [BRVO]
JCPSP-Journal of the College of Physicians and Surgeons Pakistan. 2018; 28 (7): 758-761
Dans Anglais
| IMEMR
| ID: emr-198801
ABSTRACT
Objective:
To evaluate the effectiveness of intravitreal Bevacizumab in decreasing central macular thickness in branch retinal vein occlusion [BRVO] related macular edema. StudyDesign:
Quasi experimental study. Place and Duration of Study Armed Forces Institute of Ophthalmology [AFIO], Rawalpindi, Pakistan, from March to August 2017
Recherche sur Google
Indice:
Méditerranée orientale
langue:
Anglais
Texte intégral:
J. Coll. Physicians Surg. Pak.
Année:
2018
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS